{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:20:14Z","timestamp":1789586414015,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":1183,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.14283\/jpad.2021.7","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T08:29:33Z","timestamp":1612427373000},"page":"329-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Elevated Blood Homocysteine and Risk of Alzheimer's Dementia: An Updated Systematic Review and Meta-Analysis Based on Prospective Studies"],"prefix":"10.1016","volume":"8","author":[{"given":"M.","family":"Zuin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cervellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Brombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Roncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2021.7_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1532-5415.2007.01503.x","article-title":"Mild cognitive impairment: epidemiology and dementia risk in an elderly Italian population","volume":"56","author":"Ravaglia","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib2","first-page":"64","article-title":"Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment","volume":"2","author":"Villeneuve","year":"2015","journal-title":"J Prev Alzheimer's Dis"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib4","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"10.14283\/jpad.2021.7_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J Neurochem"},{"key":"10.14283\/jpad.2021.7_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch Neurol"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jnc.12637","article-title":"Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis","volume":"129","author":"Wood","year":"2014","journal-title":"J Neurochem"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14283\/jpad.2018.47","article-title":"Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years","volume":"6","author":"van Eersel","year":"2019","journal-title":"J Prev Alzheimer's Dis"},{"issue":"8","key":"10.14283\/jpad.2021.7_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14779072.2018.1497974","article-title":"The current status of homocysteine as a risk factor for cardiovascular disease: a mini review","volume":"16","author":"Chrysant","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/nu9070725","article-title":"Plasma Homocysteine and Serum Folate and Vitamin B12 Levels in Mild Cognitive Impairment and Alzheimer's Disease: A Case-Control Study","volume":"9","author":"Ma","year":"2017","journal-title":"Nutrients"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib13","first-page":"220","article-title":"Impact of Dietary Factors and Inflammation on Cognition among Older Adults","volume":"2","author":"Handing","year":"2015","journal-title":"J Prev Alzheimer's Dis"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/aje\/kwi259","article-title":"Homocysteine and Cognitive Performance in the Framingham Offspring Study: Age Is Important","volume":"162","author":"Elias","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib15","first-page":"219","article-title":"Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation","volume":"39","author":"McCully","year":"2009","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"10.14283\/jpad.2021.7_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/nmt-2015-0008","article-title":"The relationship between hyperhomocysteinemia and neurodegeneration","volume":"6","author":"Bonetti","year":"2016","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/ajcn\/55.1.131","article-title":"The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine","volume":"55","author":"Selhub","year":"1992","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jimd.12009","article-title":"Vitamin B 12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation","volume":"42","author":"Froese","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"10.14283\/jpad.2021.7_bib19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jn\/130.8.1894","article-title":"Extremely Low Activity of Methionine Synthase in Vitamin B-12\u2013Deficient Rats May Be Related to Effects on Coenzyme Stabilization Rather than to Changes in Coenzyme Induction","volume":"130","author":"Yamada","year":"2000","journal-title":"J Nutr"},{"key":"10.14283\/jpad.2021.7_bib20","doi-asserted-by":"crossref","first-page":"108231","DOI":"10.1016\/j.jnutbio.2019.108231","article-title":"Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol","volume":"74","author":"Sugasini","year":"2019","journal-title":"J Nutr Biochem"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib21","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"9","key":"10.14283\/jpad.2021.7_bib22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2013.03.003","article-title":"Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers","volume":"66","author":"Hartling","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.14283\/jpad.2021.7_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2019-322366","article-title":"Serum homocysteine and risk of dementia in Japan","volume":"91","author":"Chen","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.14283\/jpad.2021.7_bib24","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.neurobiolaging.2006.08.012","article-title":"Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging","volume":"28","author":"Ravaglia","year":"2007","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.14283\/jpad.2021.7_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/01.WNL.0000129504.60409.88","article-title":"Plasma homocysteine levels and risk of Alzheimer disease","volume":"62","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib26","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","article-title":"Homocysteine and folate as risk factors for dementia and Alzheimer disease","volume":"82","author":"Ravaglia","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"10.14283\/jpad.2021.7_bib27","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e3181f88162","article-title":"Homocysteine and holotranscobalamin and the risk of Alzheimer disease: A longitudinal study","volume":"75","author":"Hooshmand","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.14283\/jpad.2021.7_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-150458","article-title":"Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors","volume":"49","author":"Miwa","year":"2015","journal-title":"J Alzheimer's Dis"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neurobiolaging.2009.02.024","article-title":"Midlife homocysteine and late-life dementia in women. A prospective population study","volume":"32","author":"Zylberstein","year":"2011","journal-title":"Neurobiol Aging"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1468-1331.2009.02590.x","article-title":"Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study","volume":"16","author":"Kivipelto","year":"2009","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.14283\/jpad.2021.7_bib31","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.mcn.2007.12.018","article-title":"B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-\u03b2 deposition in mice","volume":"37","author":"Fuso","year":"2008","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"10.14283\/jpad.2021.7_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.24145","article-title":"Homocysteine exacerbates \u03b2-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles","volume":"75","author":"Li","year":"2014","journal-title":"Ann Neurol"},{"issue":"2","key":"10.14283\/jpad.2021.7_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ph13020024","article-title":"Hormetic-Like Effects of L-Homocysteine on Synaptic Structure, Function, and A\u03b2 Aggregation","volume":"13","author":"Montecinos-Oliva","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib35","doi-asserted-by":"crossref","first-page":"e013368","DOI":"10.1161\/JAHA.119.013368","article-title":"Memantine Protects From Exacerbation of Ischemic Stroke and Blood Brain Barrier Disruption in Mild But Not Severe Hyperhomocysteinemia","volume":"9","author":"Gu","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.14283\/jpad.2021.7_bib36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer Disease as a Vascular Disorder","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jim-2015-000017","article-title":"Oxidative challenge in Alzheimer's disease: state of knowledge and future needs","volume":"64","author":"Cervellati","year":"2016","journal-title":"J Investig Med"},{"issue":"7","key":"10.14283\/jpad.2021.7_bib38","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2011-02-338269","article-title":"Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions","volume":"118","author":"Beard","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.14283\/jpad.2021.7_bib39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ars.2020.8076","article-title":"Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery","volume":"33","author":"Cervellati","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"10.14283\/jpad.2021.7_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2019.02.006","article-title":"Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies","volume":"51","author":"Zhou","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.14283\/jpad.2021.7_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fnagi.2018.00350","article-title":"Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia","volume":"10","author":"Price","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"23","key":"10.14283\/jpad.2021.7_bib42","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.14283\/jpad.2021.7_bib43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"Jager","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3945\/ajcn.114.103283","article-title":"Brain atrophy in cognitively impaired elderly: the importance of long-chain \u03c9-3 fatty acids and B vitamin status in a randomized controlled trial","volume":"102","author":"Jerner\u00e9n","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.14283\/jpad.2021.7_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3233\/JAD-150777","article-title":"Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment","volume":"50","author":"Oulhaj","year":"2016","journal-title":"J Alzheimer's Dis"},{"issue":"1","key":"10.14283\/jpad.2021.7_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JAD-181148","article-title":"Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study","volume":"69","author":"Jerner\u00e9n","year":"2019","journal-title":"J Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724005259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:52:55Z","timestamp":1736452375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2274580724005259"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2021.7","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated Blood Homocysteine and Risk of Alzheimer's Dementia: An Updated Systematic Review and Meta-Analysis Based on Prospective Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2021.7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}